Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How I treat adult T-cell leukemia/lymphoma
Lucy Cook, Adrienne A. Phillips
Blood (2020) Vol. 137, Iss. 4, pp. 459-470
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
Koji Izutsu, Shinichi Makita, Kisato Nosaka, et al.
Blood (2022) Vol. 141, Iss. 10, pp. 1159-1168
Open Access | Times Cited: 98
Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma
Koji Jimbo, Masanori Nojima, Keiko Toriuchi, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Aggressive T‐cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management
Shin Yeu Ong, Jasmine M. Zain
American Journal of Hematology (2024) Vol. 99, Iss. 3, pp. 439-456
Open Access | Times Cited: 8
HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation
Marcia Bellon, Christophe Nicot
Pathogens (2024) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 6
Role of Radiomics-Based Baseline PET/CT Imaging in Lymphoma: Diagnosis, Prognosis, and Response Assessment
Han Jiang, Ang Li, Zhong-You Ji, et al.
Molecular Imaging and Biology (2022) Vol. 24, Iss. 4, pp. 537-549
Closed Access | Times Cited: 24
Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia/Lymphoma
Piyanard Boonnate, Ryusho Kariya, Seiji Okada
Antioxidants (2023) Vol. 12, Iss. 4, pp. 864-864
Open Access | Times Cited: 13
Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: Immune evasion and clonal expansion
Takafumi Shichijo, Jun‐ichirou Yasunaga
Leukemia Research (2025) Vol. 152, pp. 107680-107680
Closed Access
The critical role of ferroptosis in virus-associated hematologic malignancies and its potential value in antiviral-antitumor therapy
Miao Miao, Yue‐Lei Chen, Xuehan Wang, et al.
Virulence (2025) Vol. 16, Iss. 1
Open Access
Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review
Arash Letafati, Roben Soheili, Mehdi Norouzi, et al.
Medical Oncology (2023) Vol. 40, Iss. 10
Closed Access | Times Cited: 9
A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas
Pier Paolo Piccaluga, Shaimaa Khattab
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14170-14170
Open Access | Times Cited: 8
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments
Robert Stuver, Shamir Geller
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Latency Reversing Agents: Kick and Kill of HTLV-1?
Annika P. Schnell, Stephan Kohrt, Andrea K. Thoma‐Kress
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5545-5545
Open Access | Times Cited: 16
Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)
Carmen de Mendoza, Graham P. Taylor, Antoine Gessain, et al.
NeuroImmune Pharmacology and Therapeutics (2024) Vol. 3, Iss. 1, pp. 61-69
Open Access | Times Cited: 2
Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma
Tomonaga Ichikawa, Akira Suekane, Shingo Nakahata, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2842-2842
Open Access | Times Cited: 2
Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicator for prognosis of aggressive ATL
Koji Jimbo, Toyotaka Kawamata, Yoshihiro Inamoto, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3760-3770
Open Access | Times Cited: 2
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
Anusara Daenthanasanmak, Richard N. Bamford, Makoto Yoshioka, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2346-2360
Open Access | Times Cited: 10
Functional and Pathogenic Roles of Retroviral Antisense Transcripts
Kosuke Toyoda, Masao Matsuoka
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Impact of anti-diabetic sodium-glucose cotransporter 2 inhibitors on tumor growth of intractable hematological malignancy in humans
Sawako Nakachi, Shiki Okamoto, Keita Tamaki, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112864-112864
Open Access | Times Cited: 9
Global dynamics analysis for a nonlinear HTLV-I model with logistic proliferation and CTL response
Siyu Chen, Zhijun Liu, Lianwen Wang, et al.
International Journal of Biomathematics (2023) Vol. 17, Iss. 03
Closed Access | Times Cited: 5
Liquid biopsies and minimal residual disease in lymphoid malignancies
Maroun Bou Zerdan, Joseph Kassab, Ludovic Saba, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Mature T-Cell leukemias: Challenges in Diagnosis
Dima El‐Sharkawi, Ayoma D. Attygalle, Claire Dearden
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
Rahul S. Bhansali, Stefan K. Barta
Cancers (2023) Vol. 15, Iss. 3, pp. 925-925
Open Access | Times Cited: 4
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions
Robert Stuver, Steven M. Horwitz, Zachary D. Epstein‐Peterson
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 8, pp. 948-964
Closed Access | Times Cited: 4
An update on the developments in the treatment of adult T-cell leukemia–lymphoma: current knowledge and future perspective
Junya Makiyama, Kenji Ishitsuka, Wataru Munakata, et al.
Japanese Journal of Clinical Oncology (2023) Vol. 53, Iss. 12, pp. 1104-1111
Closed Access | Times Cited: 4
Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells via modulation of NF-κB, AP-1, and Akt signaling
Chie Ishikawa, Naoki Mori
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 7, pp. 978-988
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top